Saturday, September 11, 2010

Enalapril in Fontan - No significant advantage


Double-blind trial.
Enalapril (target dose - 0.4 mg/kg/day) vs. Placebo
Enrolled 230 infants with single ventricle physiology
Followed up to 14 months of age
Primary end point: Weight at 14 months
185 completed trial
(Rest were lost to either withdrawal from trial or death/transplant - 13%)
Other measures: Height, Ross score, BNP, Bayley Scale of infant development & Ventricular ejection fraction.
Result: No difference between the two group in any of the parameters studied.
Death or Transplant occurred in 13% in either group.
Adverse reactions occurred in 88 of Enalapril group and 87 of Placebo group.


1 comment:


  1. I started on COPD Herbal treatment from Ultimate Health Home, the treatment worked incredibly for my lungs condition. I used the herbal treatment for almost 4 months, it reversed my COPD. My severe shortness of breath, dry cough, chest tightness gradually disappeared. Reach Ultimate Health Home via their email at ultimatehealthhome@gmail.com . I can breath much better and It feels comfortable!

    ReplyDelete